AnaptysBio, Inc. (ANAB)
58.74
-4.41
(-6.98%)
USD |
NASDAQ |
May 18, 16:00
59.34
+0.60
(+1.02%)
After-Hours: 04:24
AnaptysBio Research and Development Expense (Quarterly) : 33.86M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 28.44M |
| TG Therapeutics, Inc. | 48.40M |
| ADMA Biologics, Inc. | 2.597M |
| Mirum Pharmaceuticals, Inc. | 97.84M |
| Rocket Pharmaceuticals, Inc. | 30.17M |